Abstract
Eczema or atopic dermatitis (AD) is the most common chronic skin disease in children with an increasing prevalence worldwide. Atopic dermatitis often precedes asthma and allergic disorders, and several epidemiological studies provide evidence for the atopic march from AD, suggesting that AD is the starting point for subsequent allergic diseases. Most of the children develop AD before the age of 2 years, and usually AD starts during the first months of life. New insights into the pathophysiology of AD indicate that an impaired skin barrier function is strongly associated with AD, the development of asthma, and allergic disorders. However, it remains to be determined whether the development of AD is initiated by intrinsic skin barrier dysfunctions preceding altered microbial colonization of the skin resulting in skin inflammation. Further research into the etiology of AD is crucial for developing interventions in the prevention or the treatment of AD.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Anderson PC, Dinulos JG (2009) Atopic dermatitis and alternative management strategies. Curr Opin Pediatr 21:131–138
Anonymous (1993) Severity scoring of atopic dermatitis: the SCORAD index. Consensus report of the European task force on atopic dermatitis. Dermatology 186:23–31
Back O, Blomquist HK, Hernell O et al (2009) Does vitamin D intake during infancy promote the development of atopic allergy? Acta Derm Venereol 89:28–32
Badertscher K, Bronnimann M, Karlen S et al (2005) Mast cell chymase is increased in chronic atopic dermatitis but not in psoriasis. Arch Dermatol Res 296:503–506
Benn CS, Thorsen P, Jensen JS et al (2002) Maternal vaginal microflora during pregnancy and the risk of asthma hospitalization and use of antiasthma medication in early childhood. J Allergy Clin Immunol 110:72–77
Bieber T (2008) Atopic dermatitis. N Engl J Med 358:1483–1494
Bin L, Kim BE, Brauweiler A et al (2012) Staphylococcus aureus alpha-toxin modulates skin host response to viral infection. J Allergy Clin Immunol 130:683–691, e682
Boguniewicz M, Leung DY (2011) Atopic dermatitis: a disease of altered skin barrier and immune dysregulation. Immunol Rev 242:233–246
Boguniewicz M, Leung DYM (2003) Atopic dermatitis. Mosby, Philadelphia, PA
Bonnart C, Deraison C, Lacroix M et al (2010) Elastase 2 is expressed in human and mouse epidermis and impairs skin barrier function in Netherton syndrome through filaggrin and lipid misprocessing. J Clin Invest 120:871–882
Boyle RJ, Bath-Hextall FJ, Leonardi-Bee J et al (2009) Probiotics for the treatment of eczema: a systematic review. Clin Exp Allergy 39:1117–1127
Callard RE, Harper JI (2007) The skin barrier, atopic dermatitis and allergy: a role for Langerhans cells? Trends Immunol 28:294–298
Capone KA, Dowd SE, Stamatas GN et al (2011) Diversity of the human skin microbiome early in life. J Invest Dermatol 131:2026–2032
Carson CG, Halkjaer LB, Jensen SM et al (2012) Alcohol intake in pregnancy increases the child’s risk of atopic dermatitis. The COPSAC prospective birth cohort study of a high risk population. PLoS One 7:e42710
Chan SM, Turcanu V, Stephens AC et al (2012) Cutaneous lymphocyte antigen and alpha4beta7 T-lymphocyte responses are associated with peanut allergy and tolerance in children. Allergy 67:336–342
Chen H, Common JE, Haines RL et al (2011) Wide spectrum of filaggrin-null mutations in atopic dermatitis highlights differences between Singaporean Chinese and European populations. Br J Dermatol 165:106–114
De Benedetto A, Slifka MK, Rafaels NM et al (2011) Reductions in claudin-1 may enhance susceptibility to herpes simplex virus 1 infections in atopic dermatitis. J Allergy Clin Immunol 128:242–246, e245
Dekio I, Sakamoto M, Hayashi H et al (2007) Characterization of skin microbiota in patients with atopic dermatitis and in normal subjects using 16S rRNA gene-based comprehensive analysis. J Med Microbiol 56:1675–1683
Devillers AC, de Waard-van der Spek FB, Mulder PG et al (2009) Delayed- and immediate-type reactions in the atopy patch test with food allergens in young children with atopic dermatitis. Pediatr Allergy Immunol 20:53–58
Dominguez-Bello MG, Costello EK, Contreras M et al (2010) Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc Natl Acad Sci U S A 107:11971–11975
Elias PM (2008) Skin barrier function. Curr Allergy Asthma Rep 8:299–305
Fuiano N, Incorvaia C (2012) Dissecting the causes of atopic dermatitis in children: less foods, more mites. Allergol Int 61:231–243
Gibson GR, Roberfroid MB (1995) Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J Nutr 125:1401–1412
Gottrand F (2008) Long-chain polyunsaturated fatty acids influence the immune system of infants. J Nutr 138:1807S–1812S
Grice EA, Kong HH, Conlan S et al (2009) Topographical and temporal diversity of the human skin microbiome. Science 324:1190–1192
Hill DJ, Hosking CS, de Benedictis FM et al (2008) Confirmation of the association between high levels of immunoglobulin E food sensitization and eczema in infancy: an international study. Clin Exp Allergy 38:161–168
Hirasawa Y, Takai T, Nakamura T et al (2010) Staphylococcus aureus extracellular protease causes epidermal barrier dysfunction. J Invest Dermatol 130:614–617
Hodge L, Salome CM, Peat JK et al (1996) Consumption of oily fish and childhood asthma risk. Med J Aust 164:137–140
Hogan MB, Peele K, Wilson NW (2012) Skin barrier function and its importance at the start of the atopic march. J Allergy (Cairo) 2012:901940
Hollingsworth JW, Maruoka S, Boon K et al (2008) In utero supplementation with methyl donors enhances allergic airway disease in mice. J Clin Invest 118:3462–3469
Howell MD, Fairchild HR, Kim BE et al (2008) Th2 cytokines act on S100/A11 to downregulate keratinocyte differentiation. J Invest Dermatol 128:2248–2258
Howell MD, Kim BE, Gao P et al (2007) Cytokine modulation of atopic dermatitis filaggrin skin expression. J Allergy Clin Immunol 120:150–155
Illi S, Depner M, Genuneit J et al (2012) Protection from childhood asthma and allergy in Alpine farm environments: the GABRIEL advanced studies. J Allergy Clin Immunol 129:1470–1477, e1476
Kapoor R, Menon C, Hoffstad O et al (2008) The prevalence of atopic triad in children with physician-confirmed atopic dermatitis. J Am Acad Dermatol 58:68–73
Kim BE, Leung DY, Boguniewicz M et al (2008) Loricrin and involucrin expression is down-regulated by Th2 cytokines through STAT-6. Clin Immunol 126:332–337
Kong HH, Oh J, Deming C et al (2012) Temporal shifts in the skin microbiome associated with disease flares and treatment in children with atopic dermatitis. Genome Res 22:850–859
Kuo IH, Yoshida T, de Benedetto A et al (2013) The cutaneous innate immune response in patients with atopic dermatitis. J Allergy Clin Immunol 131:266–278
Kusel MM, Holt PG, de Klerk N et al (2005) Support for 2 variants of eczema. J Allergy Clin Immunol 116:1067–1072
Le TA, Takai T, Vu AT et al (2011) Flagellin induces the expression of thymic stromal lymphopoietin in human keratinocytes via toll-like receptor 5. Int Arch Allergy Immunol 155:31–37
Lehmann HS, Heaton T, Mallon D et al (2004) Staphylococcal enterotoxin-B-mediated stimulation of interleukin-13 production as a potential aetiologic factor in eczema in infants. Int Arch Allergy Immunol 135:306–312
Leung AD, Schiltz AM, Hall CF et al (2008) Severe atopic dermatitis is associated with a high burden of environmental Staphylococcus aureus. Clin Exp Allergy 38:789–793
Leung DY, Bieber T (2003) Atopic dermatitis. Lancet 361:151–160
Liang Y, Wang P, Zhao M et al (2012) Demethylation of the FCER1G promoter leads to FcεRI overexpression on monocytes of patients with atopic dermatitis. Allergy 67:424–430
Linneberg A, Petersen J, Gronbaek M et al (2004) Alcohol during pregnancy and atopic dermatitis in the offspring. Clin Exp Allergy 34:1678–1683
Martino DJ, Prescott SL (2010) Silent mysteries: epigenetic paradigms could hold the key to conquering the epidemic of allergy and immune disease. Allergy 65:7–15
Mascia F, Mariani V, Giannetti A et al (2002) House dust mite allergen exerts no direct proinflammatory effects on human keratinocytes. J Allergy Clin Immunol 109:532–538
Mclean WH, Palmer CN, Henderson J et al (2008) Filaggrin variants confer susceptibility to asthma. J Allergy Clin Immunol 121:1294–1295, Author reply 1295–1296
Naik S, Bouladoux N, Wilhelm C et al (2012) Compartmentalized control of skin immunity by resident commensals. Science 337:1115–1119
Nermes M, Kantele JM, Atosuo TJ et al (2011) Interaction of orally administered Lactobacillus rhamnosus GG with skin and gut microbiota and humoral immunity in infants with atopic dermatitis. Clin Exp Allergy 41:370–377
Niers L, Martin R, Rijkers G et al (2009) The effects of selected probiotic strains on the development of eczema (the PandA study). Allergy 64:1349–1358
Ong PY, Ohtake T, Brandt C et al (2002) Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl J Med 347:1151–1160
Palmer CN, Irvine AD, Terron-Kwiatkowski A et al (2006) Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet 38:441–446
Palmer DJ, Sullivan T, Gold MS et al (2012) Effect of n-3 long chain polyunsaturated fatty acid supplementation in pregnancy on infants’ allergies in first year of life: randomised controlled trial. BMJ 344:e184
Park JH, Choi YL, Namkung JH et al (2006) Characteristics of extrinsic vs. intrinsic atopic dermatitis in infancy: correlations with laboratory variables. Br J Dermatol 155:778–783
Pellerin L, Henry J, Hsu CY et al (2013) Defects of filaggrin-like proteins in both lesional and nonlesional atopic skin. J Allergy Clin immunol 131:1094–1102
Peroni DG, Piacentini GL, Cametti E et al (2011) Correlation between serum 25-hydroxyvitamin D levels and severity of atopic dermatitis in children. Br J Dermatol 164:1078–1082
Ring J, Darsow U, Behrendt H (2001) Role of aeroallergens in atopic eczema: proof of concept with the atopy patch test. J Am Acad Dermatol 45:S49–S52
Sano Y, Masuda K, Tamagawa-Mineoka R et al (2013) Thymic stromal lymphopoietin expression is increased in the horny layer of patients with atopic dermatitis. Clini Exp Immunol 171:330–337
Seidenari S, Giusti G (1995) Objective assessment of the skin of children affected by atopic dermatitis: a study of pH, capacitance and TEWL in eczematous and clinically uninvolved skin. Acta Derm Venereol 75:429–433
Shibata R, Kimura M, Takahashi H et al (2009) Clinical effects of kestose, a prebiotic oligosaccharide, on the treatment of atopic dermatitis in infants. Clin Exp Allergy 39:1397–1403
Spergel JM, Paller AS (2003) Atopic dermatitis and the atopic march. J Allergy Clin Immunol 112:S118–S127
Tang ML, Lahtinen SJ, Boyle RJ (2010) Probiotics and prebiotics: clinical effects in allergic disease. Curr Opin Pediatr 22:626–634
Tang TS, Bieber T, Williams HC (2012) Does “autoreactivity” play a role in atopic dermatitis? J Allergy Clin Immunol 129:1209–1215, e1202
Taylor AL, Dunstan JA, Prescott SL (2007) Probiotic supplementation for the first 6 months of life fails to reduce the risk of atopic dermatitis and increases the risk of allergen sensitization in high-risk children: a randomized controlled trial. J Allergy Clin Immunol 119:184–191
Telofski LS, Morello AP 3rd, Mack Correa MC et al (2012) The infant skin barrier: can we preserve, protect, and enhance the barrier? Dermatol Res Pract 2012:198789
Vasilopoulos Y, Cork MJ, Murphy R et al (2004) Genetic association between an AACC insertion in the 3′UTR of the stratum corneum chymotryptic enzyme gene and atopic dermatitis. J Invest Dermatol 123:62–66
Werner Y, Lindberg M (1985) Transepidermal water loss in dry and clinically normal skin in patients with atopic dermatitis. Acta Derm Venereol 65:102–105
Williams H, Stewart A, von Mutius E et al (2008) Is eczema really on the increase worldwide? J Allergy Clin Immunol 121:947–954, e915
Ziegler SF, Artis D (2010) Sensing the outside world: TSLP regulates barrier immunity. Nat Immunol 11:289–293
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 American Association of Pharmaceutical Scientists
About this chapter
Cite this chapter
Nauta, A.J., van Bever, H. (2014). The Onset of Atopic Dermatitis: Underlying Mechanisms. In: Folkerts, G., Garssen, J. (eds) Pharma-Nutrition. AAPS Advances in the Pharmaceutical Sciences Series, vol 12. Springer, Cham. https://doi.org/10.1007/978-3-319-06151-1_17
Download citation
DOI: https://doi.org/10.1007/978-3-319-06151-1_17
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-06150-4
Online ISBN: 978-3-319-06151-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)